DK3352783T3 - Vaccine omfattende immun-isolerede celler som producerer en immunmodulator - Google Patents

Vaccine omfattende immun-isolerede celler som producerer en immunmodulator Download PDF

Info

Publication number
DK3352783T3
DK3352783T3 DK16838065.7T DK16838065T DK3352783T3 DK 3352783 T3 DK3352783 T3 DK 3352783T3 DK 16838065 T DK16838065 T DK 16838065T DK 3352783 T3 DK3352783 T3 DK 3352783T3
Authority
DK
Denmark
Prior art keywords
immune
isolated cells
cells producing
vaccine including
modulator
Prior art date
Application number
DK16838065.7T
Other languages
English (en)
Inventor
Nicolas Mach
Original Assignee
Maxivax Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxivax Sa filed Critical Maxivax Sa
Application granted granted Critical
Publication of DK3352783T3 publication Critical patent/DK3352783T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891Coated capsules; Multilayered drug free capsule shells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0693Tumour cells; Cancer cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515Animal cells
    • A61K2039/5152Tumor cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55522Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/30Vaccines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK16838065.7T 2015-09-25 2016-09-26 Vaccine omfattende immun-isolerede celler som producerer en immunmodulator DK3352783T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562232940P 2015-09-25 2015-09-25
US201662384416P 2016-09-07 2016-09-07
PCT/IB2016/001968 WO2017064571A1 (en) 2015-09-25 2016-09-26 Vaccination with immuno-isolated cells producing an immunomodulator

Publications (1)

Publication Number Publication Date
DK3352783T3 true DK3352783T3 (da) 2021-11-15

Family

ID=58098658

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16838065.7T DK3352783T3 (da) 2015-09-25 2016-09-26 Vaccine omfattende immun-isolerede celler som producerer en immunmodulator

Country Status (10)

Country Link
US (2) US11013790B2 (da)
EP (1) EP3352783B1 (da)
JP (2) JP7410472B2 (da)
CN (2) CN121337966A (da)
AU (1) AU2016337411B2 (da)
CA (1) CA2998991A1 (da)
DK (1) DK3352783T3 (da)
ES (1) ES2893750T3 (da)
RU (1) RU2727697C2 (da)
WO (1) WO2017064571A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020207426A1 (zh) * 2019-04-10 2020-10-15 上海交通大学医学院附属上海儿童医学中心 一种体内植入性微孔囊袋及其使用方法和应用
WO2020228828A1 (zh) * 2019-05-15 2020-11-19 郑州威瑞生物技术有限公司 诱导免疫细胞活性的组合物及使用该组合物治疗疾病的方法
CN112316147A (zh) * 2019-08-01 2021-02-05 成都夸常奥普医疗科技有限公司 包含组织细胞的半流体和活性成分的药物组合物以及该组合物的制备方法
EP3778875A1 (en) * 2019-08-14 2021-02-17 MaxiVax SA Immortalized myoblast cell lines and uses thereof
EP3777827A1 (en) * 2019-08-14 2021-02-17 MaxiVax SA Implantable capsule
CN112924683B (zh) * 2019-12-05 2023-08-29 张曼 尿液外泌体cd40蛋白及其多肽片段在膀胱癌中的应用
CN111892648B (zh) * 2020-06-08 2022-08-26 中国科学院上海药物研究所 偶联tlr7激动剂的新型冠状病毒多肽疫苗及其应用
EP4171617A1 (en) 2020-06-30 2023-05-03 Mendus B.V. Use of leukemia-derived cells in ovarian cancer vaccines
WO2022068925A1 (zh) * 2020-09-30 2022-04-07 成都夸常奥普医疗科技有限公司 动物非致病性细胞相关组分的应用和包含该组分的药物组合物
JP2024506249A (ja) * 2021-01-22 2024-02-13 メンドゥス・ベスローテン・フェンノートシャップ 腫瘍ワクチン接種の方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680174A (en) 1984-05-24 1987-07-14 Damon Biotech, Inc. Induction of immune response by immunization with encapsulated antigen-producing cells
US5637483A (en) 1991-10-04 1997-06-10 Whitehead Institute For Biomedical Research Irradiated tumor cell vaccine engineered to express GM-CSF
US5904920A (en) 1991-10-04 1999-05-18 Whitehead Institute For Biomedical Research Regulation of systemic immune responses utilizing cytokines and antigens
US5955095A (en) 1992-04-22 1999-09-21 Brown University Research Foundation Microporous macrocapsules
AU4662393A (en) 1992-07-08 1994-01-31 Schering Corporation Use of gm-csf as a vaccine adjuvant
EP0741580A4 (en) 1993-12-14 2001-07-11 Univ Johns Hopkins Med Controlled release of pharmaceutically active substances for immunotherapy
US5795790A (en) * 1994-07-20 1998-08-18 Cytotherapeutics, Inc. Method for controlling proliferation and differentiation of cells encapsulated within bioartificial organs
US6495364B2 (en) * 1995-05-23 2002-12-17 Neurotech, S.A. Mx-1 conditionally immortalized cells
EP0930892A1 (en) 1996-10-16 1999-07-28 The Johns Hopkins University Cytokine enhanced immunotherapy for brain tumors
ATE371463T1 (de) 1997-02-05 2007-09-15 Jean-Claude Bystryn Ph-sensitive liposomen und andere typen immunomodulatoren enthaltender gekapselter impfstoffe sowie herstellungs- und anwendungsverfahren dafür
ES2218994T3 (es) 1998-02-02 2004-11-16 The Johns Hopkins University School Of Medicine Linea celular inmunomoduladora universal que expresa citocinas y composiciones relacionadas y procedimientos de fabricacion y uso.
US7250291B1 (en) 1998-08-07 2007-07-31 Dana-Farber Cancer Institute Tumor antigens and uses thereof
CA2362578A1 (en) 1999-02-09 2000-08-17 Kam Leong Tumor vaccines
AU2002213143A1 (en) 2000-10-12 2002-04-22 Institute Of Materials Research And Engineering Non-disruptive three-dimensional culture and harvest system for anchorage-dependent cells
FR2822707A1 (fr) 2001-04-03 2002-10-04 Neurotech Association d'un antigene tumoral et d'un systeme de delivrance d'une cytokine ou d'une chemokine a des fins d'immunotherapie du cancer
CA2485259A1 (en) 2002-05-07 2003-11-20 Mcmaster University Microcapsules containing biomedical materials
EP1374893A1 (en) 2002-06-17 2004-01-02 NovImmune S.A. Vaccination with immuno-isolated cells producing an immunomodulator
CA2625875C (en) * 2005-10-21 2013-12-24 Living Cell Products Pty Limited Encapsulation system
CN104640579A (zh) * 2012-05-30 2015-05-20 神经技术美国有限公司 冷冻保存的可植入细胞培养装置及其用途

Also Published As

Publication number Publication date
JP2021165313A (ja) 2021-10-14
RU2018115200A (ru) 2019-10-28
AU2016337411B2 (en) 2023-01-05
US9861689B2 (en) 2018-01-09
JP2018529706A (ja) 2018-10-11
ES2893750T3 (es) 2022-02-10
JP7410472B2 (ja) 2024-01-10
RU2727697C2 (ru) 2020-07-23
EP3352783B1 (en) 2021-08-25
US20170095546A1 (en) 2017-04-06
HK1257438A1 (en) 2019-10-18
CN108289942A (zh) 2018-07-17
RU2018115200A3 (da) 2020-02-20
US11013790B2 (en) 2021-05-25
CN121337966A (zh) 2026-01-16
EP3352783A1 (en) 2018-08-01
US20170087234A1 (en) 2017-03-30
WO2017064571A1 (en) 2017-04-20
CA2998991A1 (en) 2017-04-20
AU2016337411A1 (en) 2018-04-12

Similar Documents

Publication Publication Date Title
IL261621A (en) Genome edited immune effector cells
DK3352783T3 (da) Vaccine omfattende immun-isolerede celler som producerer en immunmodulator
EP3683960C0 (de) Photovoltaik-anlage
DK3218504T3 (da) Trisegmenterede arenavira som vaccinevektorer
DK3393510T3 (da) Zikavirusvaccine
DK3229810T3 (da) Phospholipid-ether-analoger som kræftrammende lægemiddelvehikler
PL3182466T3 (pl) Hermetyzacja modułu fotowoltaicznego
HUE053760T2 (hu) SUV39h1-deficiens immunsejtek
DK3460238T3 (da) Vindmølle
DK3255980T3 (da) Bivenlig kunstig bikage
HUE063036T2 (hu) Orális rehidráló készítmény
FI20145445A7 (fi) Järjestelmä keinotekoisen aallon muodostamiseksi
EP3388757C0 (en) HEAT-PRODUCING SYSTEM
EP3511016A4 (en) Immunostimulant
DK3450743T3 (da) Vindmølle
DK3267033T3 (da) Vindmølle
DK3532609T3 (da) Cancerdræbende celler
DK3318749T4 (da) Vindmølle
DK3450746T3 (da) Vindmølle
EP3321577A4 (en) STEAM GENERATOR
DK3604802T3 (da) Energigenereringssystem
GB201518868D0 (en) Energy generation system
GB201508509D0 (en) Tidal Energy system
DK3265671T3 (da) Vindkraftsystem
EP3693764A4 (en) ANTI-REFLECTIVE STRUCTURE